Selected research
Industry Research
Prefilled Syringes Drug Industry Research Report 2026
Market perspective
The global Prefilled Syringes Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Prefilled Syringes Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Prefilled Syringes Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Prefilled Syringes Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Prefilled Syringes Drug include Fresenius Kabi AG, AstraZeneca plc, Amgen Inc., Pfizer, Mylan N.V., Merck & Co. Inc., Novartis AG, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Prefilled Syringes Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Prefilled Syringes Drug Market by Company
Fresenius Kabi AG
AstraZeneca plc
Amgen Inc.
Pfizer
Mylan N.V.
Merck & Co. Inc.
Novartis AG
Johnson & Johnson
Sanofi
Teva Pharmaceutical Industries Ltd.
Prefilled Syringes Drug Segment by Type
Vaccines
Insulin
Adrenaline
Opioids
Others
Prefilled Syringes Drug Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Drug Stores
Prefilled Syringes Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prefilled Syringes Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Prefilled Syringes Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prefilled Syringes Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Prefilled Syringes Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Prefilled Syringes Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Prefilled Syringes Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vaccines
- Insulin
- Adrenaline
- Opioids
- Others
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
- Drug Stores
Companies covered
- Fresenius Kabi AG
- AstraZeneca plc
- Amgen Inc.
- Pfizer
- Mylan N.V.
- Merck & Co. Inc.
- Novartis AG
- Johnson & Johnson
- Sanofi
- Teva Pharmaceutical Industries Ltd.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Prefilled Syringes Drug Market Size (2021-2032)
- 2.2.2 Global Prefilled Syringes Drug Sales (2021-2032)
- 2.2.3 Global Prefilled Syringes Drug Market Average Price (2021-2032)
- 2.3 Prefilled Syringes Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Vaccines
- 2.3.3 Insulin
- 2.3.4 Adrenaline
- 2.3.5 Opioids
- 2.3.6 Others
- 2.4 Prefilled Syringes Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Hospital Pharmacies
- 2.4.5 Drug Stores
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Prefilled Syringes Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Prefilled Syringes Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Prefilled Syringes Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Prefilled Syringes Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Prefilled Syringes Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Prefilled Syringes Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Prefilled Syringes Drug, Product Type & Application
- 3.8 Global Manufacturers of Prefilled Syringes Drug, Established Date
- 3.9 Global Prefilled Syringes Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Fresenius Kabi AG
- 4.1.1 Fresenius Kabi AG Company Information
- 4.1.2 Fresenius Kabi AG Business Overview
- 4.1.3 Fresenius Kabi AG Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Fresenius Kabi AG Prefilled Syringes Drug Product Portfolio
- 4.1.5 Fresenius Kabi AG Recent Developments
- 4.2 AstraZeneca plc
- 4.2.1 AstraZeneca plc Company Information
- 4.2.2 AstraZeneca plc Business Overview
- 4.2.3 AstraZeneca plc Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AstraZeneca plc Prefilled Syringes Drug Product Portfolio
- 4.2.5 AstraZeneca plc Recent Developments
- 4.3 Amgen Inc.
- 4.3.1 Amgen Inc. Company Information
- 4.3.2 Amgen Inc. Business Overview
- 4.3.3 Amgen Inc. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amgen Inc. Prefilled Syringes Drug Product Portfolio
- 4.3.5 Amgen Inc. Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Prefilled Syringes Drug Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Mylan N.V.
- 4.5.1 Mylan N.V. Company Information
- 4.5.2 Mylan N.V. Business Overview
- 4.5.3 Mylan N.V. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan N.V. Prefilled Syringes Drug Product Portfolio
- 4.5.5 Mylan N.V. Recent Developments
- 4.6 Merck & Co. Inc.
- 4.6.1 Merck & Co. Inc. Company Information
- 4.6.2 Merck & Co. Inc. Business Overview
- 4.6.3 Merck & Co. Inc. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Merck & Co. Inc. Prefilled Syringes Drug Product Portfolio
- 4.6.5 Merck & Co. Inc. Recent Developments
- 4.7 Novartis AG
- 4.7.1 Novartis AG Company Information
- 4.7.2 Novartis AG Business Overview
- 4.7.3 Novartis AG Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Novartis AG Prefilled Syringes Drug Product Portfolio
- 4.7.5 Novartis AG Recent Developments
- 4.8 Johnson & Johnson
- 4.8.1 Johnson & Johnson Company Information
- 4.8.2 Johnson & Johnson Business Overview
- 4.8.3 Johnson & Johnson Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Johnson & Johnson Prefilled Syringes Drug Product Portfolio
- 4.8.5 Johnson & Johnson Recent Developments
- 4.9 Sanofi
- 4.9.1 Sanofi Company Information
- 4.9.2 Sanofi Business Overview
- 4.9.3 Sanofi Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sanofi Prefilled Syringes Drug Product Portfolio
- 4.9.5 Sanofi Recent Developments
- 4.10 Teva Pharmaceutical Industries Ltd.
- 4.10.1 Teva Pharmaceutical Industries Ltd. Company Information
- 4.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
- 4.10.3 Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Teva Pharmaceutical Industries Ltd. Prefilled Syringes Drug Product Portfolio
- 4.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
5 Global Prefilled Syringes Drug Market Scenario by Region
- 5.1 Global Prefilled Syringes Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Prefilled Syringes Drug Sales by Region: 2021-2032
- 5.2.1 Global Prefilled Syringes Drug Sales by Region: 2021-2026
- 5.2.2 Global Prefilled Syringes Drug Sales by Region: 2027-2032
- 5.3 Global Prefilled Syringes Drug Revenue by Region: 2021-2032
- 5.3.1 Global Prefilled Syringes Drug Revenue by Region: 2021-2026
- 5.3.2 Global Prefilled Syringes Drug Revenue by Region: 2027-2032
- 5.4 North America Prefilled Syringes Drug Market Facts & Figures by Country
- 5.4.1 North America Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Prefilled Syringes Drug Sales by Country (2021-2032)
- 5.4.3 North America Prefilled Syringes Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Prefilled Syringes Drug Market Facts & Figures by Country
- 5.5.1 Europe Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Prefilled Syringes Drug Sales by Country (2021-2032)
- 5.5.3 Europe Prefilled Syringes Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Prefilled Syringes Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Prefilled Syringes Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Prefilled Syringes Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Prefilled Syringes Drug Market Facts & Figures by Country
- 5.7.1 South America Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Prefilled Syringes Drug Sales by Country (2021-2032)
- 5.7.3 South America Prefilled Syringes Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Prefilled Syringes Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Prefilled Syringes Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Prefilled Syringes Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Prefilled Syringes Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Prefilled Syringes Drug Sales by Type (2021-2032)
- 6.1.1 Global Prefilled Syringes Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Prefilled Syringes Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Prefilled Syringes Drug Revenue by Type (2021-2032)
- 6.2.1 Global Prefilled Syringes Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Prefilled Syringes Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Prefilled Syringes Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Prefilled Syringes Drug Sales by Application (2021-2032)
- 7.1.1 Global Prefilled Syringes Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Prefilled Syringes Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Prefilled Syringes Drug Revenue by Application (2021-2032)
- 7.2.1 Global Prefilled Syringes Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Prefilled Syringes Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Prefilled Syringes Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Prefilled Syringes Drug Value Chain Analysis
- 8.1.1 Prefilled Syringes Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Prefilled Syringes Drug Production Mode & Process
- 8.2 Prefilled Syringes Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Prefilled Syringes Drug Distributors
- 8.2.3 Prefilled Syringes Drug Customers
9 Global Prefilled Syringes Drug Analyzing Market Dynamics
- 9.1 Prefilled Syringes Drug Industry Trends
- 9.2 Prefilled Syringes Drug Industry Drivers
- 9.3 Prefilled Syringes Drug Industry Opportunities and Challenges
- 9.4 Prefilled Syringes Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst